Literature DB >> 28752373

Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.

Carolyn Jean Chua-Aguilera1, Burkhard Möller2, Nikhil Yawalkar3.   

Abstract

Extra-articular manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and various spondyloarthritides including psoriatic arthritis, ankylosing spondylitis, reactive arthritis, and inflammatory bowel disease-associated spondyloarthritis often involve the skin and may occur before or after diagnosis of these rheumatic diseases. Cutaneous manifestations encompass a wide range of reactions that may have a notable negative impact not only on the physical but especially on the emotional and psychosocial well-being of these patients. Several cutaneous manifestations have been related to rheumatoid arthritis such as subcutaneous nodules including classical rheumatoid nodules, accelerated rheumatoid nodulosis, and rheumatoid nodulosis; vascular disorders like rheumatoid vasculitis, livedo racemosa, and Raynaud's phenomenon; and neutrophilic and/or granulomatous diseases like pyoderma gangrenosum, Sweet's syndrome, rheumatoid neutrophilic dermatitis, interstitial granulomatous dermatitis with arthritis, as well as palisaded neutrophilic and granulomatous dermatitis. In juvenile idiopathic arthritis, the main cutaneous manifestations include an evanescent rash, rheumatoid nodules, as well as plaque and guttate psoriasis. Plaque psoriasis is also the main skin disease involved in spondyloarthritides. Furthermore, other forms of psoriasis including guttate, inverse, erythrodermic, pustular, and particularly nail psoriasis may also occur. In addition, a variety of drug-induced skin reactions may also appear in these diseases. Early recognition and understanding of these different dermatologic manifestations together with an interdisciplinary approach are often needed to optimize management of these diseases.

Entities:  

Keywords:  DMARDs; Inflammatory bowel disease; Juvenile idiopathic arthritis; Psoriasis; Rheumatoid arthritis; Spondyloarthritis

Mesh:

Year:  2017        PMID: 28752373     DOI: 10.1007/s12016-017-8632-5

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  130 in total

1.  Interstitial Granulomatous Dermatitis: A Clinicopathological Study.

Authors:  Inês Coutinho; Neide Pereira; Miguel Gouveia; José Carlos Cardoso; Oscar Tellechea
Journal:  Am J Dermatopathol       Date:  2015-08       Impact factor: 1.533

2.  Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept.

Authors:  Paul S Yamauchi; Logan Turner; Nicholas J Lowe; Vivian Gindi; J Mark Jackson
Journal:  J Am Acad Dermatol       Date:  2006-03       Impact factor: 11.527

3.  Interstitial granulomatous dermatitis with arthritis presenting with the rope sign.

Authors:  F S Worsnop; L Ostlere
Journal:  Clin Exp Dermatol       Date:  2013-03-27       Impact factor: 3.470

Review 4.  Reactive arthritis.

Authors:  Timo Hannu
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-06       Impact factor: 4.098

5.  Red lunulae in a patient with rheumatoid arthritis.

Authors:  J L Jorizzo; E B Gonzalez; J C Daniels
Journal:  J Am Acad Dermatol       Date:  1983-05       Impact factor: 11.527

Review 6.  Rheumatoid arthritis in dermatology.

Authors:  Tissa Hata; Arthur Kavanaugh
Journal:  Clin Dermatol       Date:  2006 Sep-Oct       Impact factor: 3.541

Review 7.  Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand.

Authors:  Cairistin McDougall; Kelle Hurd; Cheryl Barnabe
Journal:  Semin Arthritis Rheum       Date:  2016-11-01       Impact factor: 5.532

8.  Statistical reappraisal of the clinical significance of nail beading in rheumatoid arthritis.

Authors:  E N Grant; N Bellamy; W W Buchanan; E M Grace; S O'Leary
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

9.  Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

Authors:  Alan Menter; Neil J Korman; Craig A Elmets; Steven R Feldman; Joel M Gelfand; Kenneth B Gordon; Alice B Gottlieb; John Y M Koo; Mark Lebwohl; Henry W Lim; Abby S Van Voorhees; Karl R Beutner; Reva Bhushan
Journal:  J Am Acad Dermatol       Date:  2009-06-03       Impact factor: 11.527

10.  Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology.

Authors:  Nastya Kharlamova; Xia Jiang; Natalia Sherina; Barbara Potempa; Lena Israelsson; Anne-Marie Quirke; Kaja Eriksson; Tülay Yucel-Lindberg; Patrick J Venables; Jan Potempa; Lars Alfredsson; Karin Lundberg
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

View more
  12 in total

Review 1.  Autoimmunity in 2017.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

2.  [Clinical characteristics and biological treatment of adult patient with juvenile idiopathic arthritis].

Authors:  S X Wei; S J Li; Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

Review 3.  Cutaneous Granulomatosis: a Comprehensive Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Carlo Mainetti; Marie-Astrid Peeters; Emmanuel Laffitte
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Cutaneous manifestations are frequent and diverse among patients with rheumatoid arthritis and impact their quality of life: a cross-sectional study in a cohort of patients with recent-onset disease.

Authors:  Gabriela Sánchez-Cárdenas; Irazú Contreras-Yáñez; Guillermo Guaracha-Basáñez; Lexli D Pacheco-Santiago; Silvia Méndez-Flores; Ana Barrera-Vargas; Javier Merayo-Chalico; Judith Domínguez-Cherit; Virginia Pascual-Ramos
Journal:  Clin Rheumatol       Date:  2021-03-02       Impact factor: 2.980

5.  Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn's Disease.

Authors:  Evan Darwin; Amar Deshpande; Hadar Lev-Tov
Journal:  ACG Case Rep J       Date:  2018-06-20

6.  Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis.

Authors:  Noritada Yoshikawa; Erika Matsubara; Motohisa Yamamoto; Hiroki Yamazaki; Masaaki Uehara; Masahiro Kamata; Hirotoshi Tanaka
Journal:  Intern Med       Date:  2020-07-07       Impact factor: 1.271

7.  Demodex Species Frequency and Risk Factors in Patients With Rheumatoid Arthritis.

Authors:  Hatice Yazisiz; Yeşim Çekİn; İlhan Sezer; Feyzi Bostan; Fatma Gülsüm KoÇlar
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

Review 8.  Skin manifestations in spondyloarthritis.

Authors:  Katharina Meier; Alexandra Schloegl; Denis Poddubnyy; Kamran Ghoreschi
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

9.  Rheumatoid neutrophilic dermatitis.

Authors:  Gabriela Żuk; Kamila Jaworecka; Dominik Samotij; Elżbieta Ostańska; Adam Reich
Journal:  Reumatologia       Date:  2019-12-31

Review 10.  A20: a master regulator of arthritis.

Authors:  Yongyao Wu; Xiaomin He; Ning Huang; Jiayun Yu; Bin Shao
Journal:  Arthritis Res Ther       Date:  2020-09-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.